HE4 and other markers in ovarian cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F13%3A10133143" target="_blank" >RIV/00669806:_____/13:10133143 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
HE4 and other markers in ovarian cancer
Original language description
The goal of this study was to evaluate the utility of anti-Müllerian hormone (AMH) serum levels for prediction of gonadotropin dose for stimulation prior to an IVF cycle. In conclusion, AMH is a good predictor for the dose of gonadotropins. A lower valueof AMH corresponds with the high consumption of gonadotropins during the stimulation process. A low level of AMH predicts a high dose of gonadotropins, required during stimulation and also predicts a poorer yield of oocytes.
Czech name
—
Czech description
—
Classification
Type
D - Article in proceedings
CEP classification
FK - Gynaecology and obstetrics
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Article name in the collection
17th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI)
ISBN
978-88-6521-063-5
ISSN
—
e-ISSN
—
Number of pages
3
Pages from-to
173-175
Publisher name
Monduzzi Editoriale S.r.l.
Place of publication
Milano - Italy
Event location
Lisbon, Portugal
Event date
Nov 8, 2012
Type of event by nationality
WRD - Celosvětová akce
UT code for WoS article
—